These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28400543)

  • 1. [I. Identification of a Possible Therapeutic Target for Chondrosarcoma with IDH Mutant Inhibitors].
    Nakagawa M; Nakatani F; Kitabayashi I
    Gan To Kagaku Ryoho; 2017 Mar; 44(3):212-216. PubMed ID: 28400543
    [No Abstract]   [Full Text] [Related]  

  • 2. The biology and management of cartilaginous tumors: a role for targeting isocitrate dehydrogenase.
    Tinoco G; Wilky BA; Paz-Mejia A; Rosenberg A; Trent JC
    Am Soc Clin Oncol Educ Book; 2015; ():e648-55. PubMed ID: 25993236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism: IDH2 drives cancer in vivo.
    Lokody I
    Nat Rev Cancer; 2013 Nov; 13(11):756-7. PubMed ID: 24132108
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticancer drugs: IDH2 drives cancer in vivo.
    Lokody I
    Nat Rev Drug Discov; 2013 Nov; 12(11):826-7. PubMed ID: 24172328
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic Targets and Emerging Treatments in Advanced Chondrosarcoma.
    Miwa S; Yamamoto N; Hayashi K; Takeuchi A; Igarashi K; Tsuchiya H
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of sarcomas by mutant IDH2.
    Lu C; Venneti S; Akalin A; Fang F; Ward PS; Dematteo RG; Intlekofer AM; Chen C; Ye J; Hameed M; Nafa K; Agaram NP; Cross JR; Khanin R; Mason CE; Healey JH; Lowe SW; Schwartz GK; Melnick A; Thompson CB
    Genes Dev; 2013 Sep; 27(18):1986-98. PubMed ID: 24065766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.
    Li L; Paz AC; Wilky BA; Johnson B; Galoian K; Rosenberg A; Hu G; Tinoco G; Bodamer O; Trent JC
    PLoS One; 2015; 10(9):e0133813. PubMed ID: 26368816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic utility of IDH1/2 mutations to distinguish dedifferentiated chondrosarcoma from undifferentiated pleomorphic sarcoma of bone.
    Chen S; Fritchie K; Wei S; Ali N; Curless K; Shen T; Brini AT; Latif F; Sumathi V; Siegal GP; Cheng L
    Hum Pathol; 2017 Jul; 65():239-246. PubMed ID: 28552826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of IDH mutations in chondrosarcoma.
    Nakagawa M; Sekimizu M; Endo M; Kobayashi E; Iwata S; Fukushima S; Yoshida A; Kitabayashi I; Ichikawa H; Kawai A; Nakatani F
    J Orthop Sci; 2022 Nov; 27(6):1315-1322. PubMed ID: 34531086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of mutant IDH1 by DS-1001b ameliorates aberrant histone modifications and impairs tumor activity in chondrosarcoma.
    Nakagawa M; Nakatani F; Matsunaga H; Seki T; Endo M; Ogawara Y; Machida Y; Katsumoto T; Yamagata K; Hattori A; Fujita S; Aikawa Y; Ishikawa T; Soga T; Kawai A; Chuman H; Yokoyama N; Fukushima S; Yahiro K; Kimura A; Shimada E; Hirose T; Fujiwara T; Setsu N; Matsumoto Y; Iwamoto Y; Nakashima Y; Kitabayashi I
    Oncogene; 2019 Oct; 38(42):6835-6849. PubMed ID: 31406254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isocitrate dehydrogenase mutations in chondrosarcoma: the crossroads between cellular metabolism and oncogenesis.
    Azzi G; Velez M; Mathias-Machado MC
    Curr Opin Oncol; 2014 Jul; 26(4):403-7. PubMed ID: 24867810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IDH mutations: new genetic signatures in cholangiocarcinoma and therapeutic implications.
    Borger DR; Zhu AX
    Expert Rev Anticancer Ther; 2012 May; 12(5):543-6. PubMed ID: 22594888
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel therapeutic approaches in chondrosarcoma.
    Polychronidou G; Karavasilis V; Pollack SM; Huang PH; Lee A; Jones RL
    Future Oncol; 2017 Mar; 13(7):637-648. PubMed ID: 28133974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IDH1 Mutation Induces HIF-1
    Hu X; Li L; Eid JE; Liu C; Yu J; Yue J; Trent JC
    Dis Markers; 2022; 2022():7729968. PubMed ID: 35198082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant IDH regulates glycogen metabolism from early cartilage development to malignant chondrosarcoma formation.
    Pathmanapan S; Poon R; De Renshaw TB; Nadesan P; Nakagawa M; Seesankar GA; Ho Loe AK; Zhang HH; Guinovart JJ; Duran J; Newgard CB; Wunder JS; Alman BA
    Cell Rep; 2023 Jun; 42(6):112578. PubMed ID: 37267108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enigmas of IDH mutations in hematology/oncology.
    Heuser M; Araujo Cruz MM; Goparaju R; Chaturvedi A
    Exp Hematol; 2015 Aug; 43(8):685-97. PubMed ID: 26032956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting glutaminolysis in chondrosarcoma in context of the IDH1/2 mutation.
    Peterse EFP; Niessen B; Addie RD; de Jong Y; Cleven AHG; Kruisselbrink AB; van den Akker BEWM; Molenaar RJ; Cleton-Jansen AM; Bovée JVMG
    Br J Cancer; 2018 Apr; 118(8):1074-1083. PubMed ID: 29576625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional chondrosarcoma with focal clear cell change: a clinicopathological and molecular analysis.
    Lam SW; van Langevelde K; Suurmeijer AJH; Cleven AHG; Bovée JVMG
    Histopathology; 2019 Dec; 75(6):843-852. PubMed ID: 31297850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
    Denu RA; Yang RK; Lazar AJ; Patel SS; Lewis VO; Roszik J; Livingston JA; Wang WL; Shaw KR; Ratan R; Zarzour MA; Bird J; Raza S; Akdemir KC; Rodon Ahnert J; Subbiah V; Patel S; Conley AP
    Clin Cancer Res; 2023 Dec; 29(23):4844-4852. PubMed ID: 37747813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CORR Insights®: Are IDH1 R132 Mutations Associated With Poor Prognosis in Patients With Chondrosarcoma of the Bone?
    Ramsey DC
    Clin Orthop Relat Res; 2024 Jun; 482(6):957-959. PubMed ID: 38446419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.